Tovorafenib, Tovorafenib
DAY101-001
Phase 2 small_molecule active
Quick answer
Tovorafenib, Tovorafenib for RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors in pediatric patients is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors in pediatric patients
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active